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Zinc oxide nanoparticles (ZnO NPs) are one of the most well-known materials in the field of nanotechnology. 
Adopting a more environmentally friendly synthesis methods of ZnO NPs have been the focus in the last 
few decades. Of all green synthesis methods of ZnO NPs, fabrication with the help of plant extracts has been 
the most popular due to its many benefits. The use of phytofabricated ZnO NPs in anticancer studies has 
been conducted increasingly over the last decade because of its high inhibition activity against various types 
of cancerous cells. This short review article will present the current update on the phytofabrication of ZnO 
NPs in recent years and discuss on their cytotoxicity mechanism against cancer cells.  
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1. Introduction  
Year by year, the number of people diagnosed with various types of cancer are increasing 
around the globe. It is estimated by the year 2030, the number of deaths from cancer will be around 
~21 million, making it one of the major cause of morbidity and mortality in the world [1, 2]. Therefore, 
effective cancer screening and therapy have to be developed to solve this highly concerning issue. 
The main problems with current anticancer chemotherapy usually involve development of drug 
resistance and difficulty to differentiate between cancerous and healthy cells thus causing severe side 
effects to patients.  
In recent years, researchers have been experimenting on the application of nanotechnology in 
cancer therapy using different types of nanoparticles. In this regard, several studies have shown that 
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zinc oxide (ZnO) nanoparticles have high potential to be used as anticancer agent due to its high 
selectivity of cancer cells and effective cytotoxic activities. ZnO also has good biocompatibility level 
as it is graded as a “GRAS” (generally recognized as safe) substance by the US Food and Drug 
Administration (FDA). Therefore, they are commonly used in food industries for packaging and 
improving shelf life of food [3]. Chemically, the surface of ZnO is rich in hydroxyl (–OH) groups, 
which allows ZnO to slowly dissolve in both acidic (tumor microenvironment) and strong basic 
conditions. By aiming the specific cites of cancer cells, drug delivery based on the use of ZnO NPs 
could reduce the dosage of drugs used for treatment and reduce other side effects. The biodegradable 
properties and low toxicity of ZnO NPs have increased its usage in cancer drug delivery compared 
to other nanoparticles. The solubility and toxicity of ZnO NPs can also be improved by loading it 
with current anticancer drugs such as baicalin, doxorubicin, curcumin, and paclitaxel [4]. Based on 
these promising properties, ZnO NPs have gained immense interest in biomedical applications 
especially in anticancer diagnostics and therapy [5].  
Intermediate metals nanoparticles produced by physicochemical and or green synthesis 
methods include silver, gold, platinum, palladium, as well as metal oxides such as copper oxide, zinc 
oxide, etc., often have medical applications in inhibiting disease such as bacterial, microbe, fungi and 
viruses as well [6-11].   
Among different approaches and techniques used to synthesize ZnO NPs, green synthesis 
using biological sources such as plants, microbes and other natural elements has been generally 
accepted by researchers due to its many advantages as compared to other methods. Conventional 
methods like chemical and physical approaches usually uses toxic chemicals that are detrimental to 
the environment and human health, requires high amount of energy and advanced laboratory 
equipment [7]. On the other hand, green synthesis methods are eco-friendly, uses non-hazardous 
reagents, simple and cost-effective [4]. This short review aims to report on the latest publications of 
ZnO NPs biosynthesized using plant sources as well as discussing their cytotoxic potential and 
general mechanism against cancerous cells.  
 
2. Phytofabrication of zinc oxide nanoparticles 
 In the process of fabricating nanoparticles, several approaches can be adopted such as 
physical, chemical and green synthesis methods. Out of these three methods, green synthesis of 
nanoparticles has gained prominence in the last several decades due to its many advantages. Green 
synthesis is categorized under ‘bottom to up’ approach for creating nanoparticles, which means that 
the construction process starts from metal atoms assembling to form clusters, and eventually the 
desired nanoparticles. The main components needed to form nanoparticles are metal salt (precursor), 
reducing agent and stabilizing agent.  
Green synthesis using plant sources or phytofabrication has been one of the most well studied 
technique in producing ZnO NPs. Phytofabrication makes use of biomolecules and secondary 
metabolites in plant extracts such as tannins, flavonones, saponins, polyphenols, alkaloids, and 
terpenoids [4]. These compounds act as a reducing agent and are mainly responsible for the effective 
reduction of zinc precursors to nanoparticles. Some compounds might also play the role of stabilizing 
agents as it can control the size of nanoparticles produced during the synthesis process. Plant extracts 
can be made from various parts of plants such as their leaf, flowers, fruits, fruit peels and many more. 
Table 1 shows a list of plants that have been utilized to synthesize ZnO NPs and its application 
towards different types of cancerous cells. Compared to other green synthesis methods, 
phytofabrication is usually favored due to the high concentrations of chemical constituents they 
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contain, low cost, ecological, non-hazardous and bio-compatible. Other than that, it is generally safe 
as it does not involve the use of microorganisms and large-scale production is highly plausible [4].  
  
Table 1. Zinc oxide nanoparticles synthesized from various plants and their cytotoxic potential. 
No. Type of plants  Parts Zinc oxide NPs 
morphology 
Target cancer cells Ref. 
1 Bergenia ciliate Rhizome ~30 nm, flower 
shaped 
Human cervical cancer 





Leaf 30-48.5 nm, 
polygonal and 
hexagonal 
Colon carcinoma (HCT 116) 










65-239.6 nm, flower 
and spheroid shapes 
Human lung cancer (A549) [10] 
5 Banana Peel 81.22-526.52 nm, rod 
and sheet-like 
shapes 
Skin cancer (A431), 
colorectal cancer (SW620) 








Peel 28.42 nm, spherical Neuroblastoma (SH-SY5Y) [12] 
8 Acantholimun 
serotinum 
Aerial 20-80 nm, spherical Human colon cancer (Caco-
2), neuroblastoma (SH-
SY5Y), breast cancer (MDA-





Leaf 177-249 nm, 
irregular and rod-
like 
Lung cancer cell (A549) [14] 
10 Deverra 
tortuosa 
Aerial 9.26-31.18 nm Human colon cancer (Caco-
2) and human lung cancer 
(A549) 
[5] 





Leaf ~45 nm, spherical Human skin cancer (A431) [16] 
13 Cratoxylum 
formosum 
Leaf ~500 nm, spherical 
or sheet-like 
structures 
Non-melanoma skin cancer 







10-15 nm, spherical Esophageal squamous 
cancer (EC109 and TE8) 
[18] 
15 Delonix regia 
(Gul Mohar) 




HeLa cancer cell line [3] 
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16 Albizia lebbeck Stem bark 66.25 – 112.87 nm, 
spherical/irregular 
Breast cancer (MDA-MB-









Leaf 50-200 nm,  Breast cancer (MCF-7) and 






Fruit peel 32.98 – 81.84 nm, 
hexagonal and 
spherical 





- ~10 nm, spherical Human non-small cell lung 
cancer (A549) 
[23] 
21 Sechium edule Leaf 36.2 nm, spherical  Breast cancer (MCF-7) [24] 
22 Ziziphus 
nummularia 
Leaf 17.33 nm, 
spherical/irregular  
HeLa cancer cell line [25] 
 
3. Cytotoxic potential of zinc oxide nanoparticles 
 Most published anticancer studies using phytofabricated ZnO NPs reported efficient in vitro 
cytotoxicity against various cancer cells in a dose dependent manner. A study by Banzeer et al. 
reported the highest inhibition potential of liver cancer cells (HepG2) of up to ~71% mortality at 1000 
μg/mL and the potency of its phytofabricated ZnO NPs was decreasing in lower concentration [1]. 
Several studies also reported higher inhibition of cancer cells by ZnO NPs when compared to the 
respective plant extracts used to synthesize them. For example, Z. Nummularia leaf extract inhibited 
HeLa cancer cells to about 40% while the phytofabricated ZnO NPs successfully inhibited around 
50% at 50 μg/mL concentrations [13, 25]. This is probably due to the synergistic effects of bioactive 
phytocompounds from plant extract present on the surface of ZnO NPs leading to enhanced 
bioavailability and cytotoxicity. While majority of papers reported increased cytotoxicity potential of 
ZnO NPs in higher concentration, a study by Kanika et al. found that low dosage of ZnO NPs has 
been very effective against liver cancer (HepG2) and breast cancer (MCF-7). The cell viability of 
HepG2 cells in particular was less than 10% at a low concentration of only 25 μg/mL [8].  
In terms of selectivity, ZnO NPs have proven to be highly selective towards cancer cells in 
several papers. In a published report by Damita Jevapatarakul et al., all phytofabricated ZnO NPs 
were found to inhibit non-melanoma skin cancer cells without affecting normal cells. They also 
reported that ZnO nanosheets were observed to have more potent anticancer activities compared to 
spherical ZnO NPs [17]. A study by Jittiporn et al. also mentioned that their ZnO nanorods and 
nanosheets successfully inhibited viability of all tested cancer cells without affecting normal cell 
(Vero) [11]. Another method to significantly increase selectivity of ZnO NPs towards cancer cells 
include loading them with other conventional cancer drugs.  
Figure 1 shows the illustration of generally discussed anticancer mechanisms of ZnO NPs. 
The ZnO NPs and ions usually enter into cancer cells by damaging their cell wall and membrane 
protein or through electron transport process. Positive charge of ZnO NPs surface plays an important 
role in enabling better binding of the NPs to the negatively charge cancer cells by endocytosis and 
cellular transportation [3]. Subsequently, as there are elevated amounts of intracellular zinc particles, 
protein action disequilibrium happens and cytotoxicity process will be initiated [20]. During this 
process, proteins and enzymes will undergo denaturation, and other organelles such as mitochondria 
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and DNA will be damaged. The ZnO NPs will stimulate reactive oxygen species (ROS) production 
which eventually result in oxidative damage of organelles and cell apoptosis. This ROS action is 
induced through pro-inflammatory reaction of the cell against ZnO-NPs as well as the characteristic 
surface property of the nanoparticles that makes ZnO NPs act as a redox system [5]. Other than that, 
ZnO NPs are known to stimulate cell surface receptors resulting in provoking of caspase-8 and 
commencement of caspace cascade in the death receptor pathway. This activation will lead to 
apoptosis and necrosis of cells [3]. Basic signs that indicate apoptosis in cells can be observed 
following 48 hours of incubation with the phytofabricated ZnO NPs. An example can be seen from a 
study by Huzaifa et al. where membrane blebs can be seen on MDA-MB 231 and MCF-7 cancer cells 
after incubation with ZnO NPs phytofabricated with A. lebbeck stem bark [19]. Similarly, Abdul Aziz 
et al. in his study found that the ZnO NPs-treated colon cancer cells showed a loss of anchorage from 
the culture flasks, a phenomenon known as “anoikis” after 48 hours. They also observed deformed 
and shrunken cells with distorted or fragmented nuclei, providing visual images of cellular damage. 
Interestingly, the ZnO-NP-treated colon cells further displayed the presence of single, conspicuously 
large, bubble-like cells clearly suggestive of the occurrence of necrosis. Therefore, the cytotoxicity of 
ZnO NPs are mediated by highly regulated and genetically controlled apoptosis-necrosis continuum 
(“necroptosis”) [9].  
 
 
Figure 1. Anticancer mechanism of zinc oxide nanoparticles. 
 
4. Future outlook and conclusions 
Even though ZnO NPs shows an excellent potential to be used as an anticancer agent, there 
are also several loopholes that need to be studied and experimented. Firstly, there is a genuine 
absence of in vivo utilization of NPs in cancer treatment studies [20]. There should be a joint effort 
between clinicians, researcher and material researchers to further evaluate on the toxicity and 
biocompatibility of these phytofabricated ZnO NPs in different animal models and finally utilized in 
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clinical applications [1]. Without in vivo studies, all the in vitro research will be redundant and making 
no further progress. Next, one of the most prominent disadvantages of metal oxide nanoparticles 
such as ZnO NPs is its increased toxicity levels due to accumulation and agglomeration. As there are 
a lot of free energy in these nanoparticles, agglomeration process might occur making them less 
effective for drug delivery process. Therefore, future research should focus on minimizing this 
problem so that the cytotoxicity potential of ZnO NPs can be efficiently utilized [26]. Accumulation 
of these nanoparticles in the environment has also becoming a highly concerning problem as the field 
of nanotechnology has expanded. Regulatory agencies should play a crucial role in adopting new 
guidelines and assessing the safety measures of these nanoparticles to prevent unwanted ecological 
problems in the future [26].   
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